Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/14/2000EP1007067A1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium
06/14/2000EP1007066A1 Steroid receptor binding compositions and steroid-sparing preparations thereof in immunosuppression and inflammation
06/14/2000EP1007064A1 Regeneration of nerves in the central nervous system
06/14/2000EP1007059A1 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
06/14/2000EP1007058A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS IN COMBINATION THERAPY FOR TREATING HEPATITIS VIRUS INFECTIONS
06/14/2000EP1007057A1 Method of treating herpes infections
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007055A1 Methods for the administration of amifostine
06/14/2000EP1007054A1 Liquid alendronate formulations
06/14/2000EP1007053A1 Treatment of pain
06/14/2000EP1007052A1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
06/14/2000EP1007051A1 Integrin receptor antagonists
06/14/2000EP1007050A1 Method for treating substance abuse
06/14/2000EP1007049A1 New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
06/14/2000EP1007048A1 Identification of agents for use in the treatment of alzheimer's disease
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007046A1 Method for treatment of chronic bronchitis
06/14/2000EP1007045A1 Topical application of opioid analgesic drugs such as morphine
06/14/2000EP1007044A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
06/14/2000EP1007043A1 Method for treatment of cns-involved lysosomal storage diseases
06/14/2000EP1007042A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
06/14/2000EP1007041A1 Composition for treating pain
06/14/2000EP1007040A1 Use of phanquinone for the treatment of alzheimer's disease
06/14/2000EP1007039A1 Novel heterocyclic analogs of diphenylethylene compounds
06/14/2000EP1007038A2 Anti-inflammatory agent
06/14/2000EP1007037A1 Antithrombotic agents
06/14/2000EP1007036A1 Methods of using butyric acid or butyric acid derivatives to protect against hair loss
06/14/2000EP1007035A1 Polythiophene anti-tumor agents
06/14/2000EP1007034A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP1007032A1 4-cyano-4-deformylsordaricin derivatives
06/14/2000EP1007031A1 4-cyano-4-deformylsordarin derivatives
06/14/2000EP1007030A1 Solid pharmaceutical composition containing benzofurane derivatives
06/14/2000EP1007029A1 Methods and compositions for treatment of ovarian cancer
06/14/2000EP1007028A1 8-iso-prostaglandins for glaucoma therapy
06/14/2000EP1007027A2 Synthetically prepared composition for treatment and/or prophylaxis of overweight, and use thereof
06/14/2000EP1007026A1 Integrin antagonists
06/14/2000EP1007025A1 Use of hydroxyguanidines
06/14/2000EP1007024A1 Delayed-release dosage forms of sertraline
06/14/2000EP1007023A1 Medical treatment
06/14/2000EP1007021A1 Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
06/14/2000EP1007020A1 Treatment of cell-mediated immune diseases
06/14/2000EP1007019A2 Cholesterol-lowering therapy
06/14/2000EP1007018A2 The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
06/14/2000EP1007017A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
06/14/2000EP1007014A1 Transdermal, hormone-delivering therapeutic system
06/14/2000EP1007013A1 Parenteral pimaricin as treatment of systemic infections
06/14/2000EP1007012A1 Taste-masked microcapsule compositions and methods of manufacture
06/14/2000EP1007010A2 Pharmaceutical composition comprising an azasteroid
06/14/2000EP1007009A1 A pharmaceutical composition having two coating layers
06/14/2000EP1007008A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol
06/14/2000EP1007007A1 Ascorbic acid-based formulation with improved colour stability
06/14/2000EP1007006A1 Cefadroxil monohydrate tablet formulation
06/14/2000EP1007003A1 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
06/14/2000EP1007001A2 Nimesulide topical formulations in the form of liquid crystals
06/14/2000EP1006999A2 Use of submicron oil-in-water emulsions with dna vaccines
06/14/2000EP1006998A1 Topical drug preparations
06/14/2000EP1006996A1 USE OF 17-$g(a)-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY
06/14/2000EP1006984A1 Monohydric alcohol derived urethanes and their use in cosmetic formulations
06/14/2000EP1006969A1 Intranasal formulations for promoting sleep and method of using the same
06/14/2000EP1006964A1 Intrauterine chemical necrosing method, composition, and apparatus
06/14/2000EP1006814A1 Edible, low calorie compostions of a carrier and an active ingredient and methods for preparation thereof
06/14/2000EP1006798A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
06/14/2000EP1006797A1 Serpin enzyme complex receptor-mediated gene transfer
06/14/2000EP1006794A1 A method for treating or preventing alzheimer's disease
06/14/2000EP1006793A1 Anti-arrhythmic composition and methods of treatment
06/14/2000EP0901463B1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
06/14/2000EP0871606B1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
06/14/2000EP0845985B1 Non-steroidal sulfatase inhibitor compounds
06/14/2000EP0830145B1 Formulations comprising leflunomide
06/14/2000EP0823892B1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
06/14/2000EP0822812A4 Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines
06/14/2000EP0820426B1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION
06/14/2000EP0746326A4 Oligomeric compounds having nitrogen-containing linkages
06/14/2000EP0693932A4 Methods and compositions for inducing phase separation of epithelial lipid bilayers
06/14/2000EP0525057B1 Antimicrobial quinolonyl lactams
06/14/2000CN1256700A Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles,and method for making and using the same
06/14/2000CN1256692A 4-phenylpiperidine compound
06/14/2000CN1256691A 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
06/14/2000CN1256687A Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP
06/14/2000CN1256633A Antibacterial composition for topical administration containing antibiotics
06/14/2000CN1256632A Suppression of malignancy utilizing ribonucleotide reductase R1
06/14/2000CN1256631A Methods and composition for treating fungal infections in mannals
06/14/2000CN1256630A Parvitamin A correlation molecule for treating non-insulin dependent diabetes mellitus (NIDDM)
06/14/2000CN1256629A Therapeutic compositions
06/14/2000CN1256628A Sustained-release compositions and method for preparing same
06/14/2000CN1256617A Feed coposition for broilers and method for breeding broilers
06/14/2000CN1256313A Method for fermentation production of D-pantothenic acid using corynebacteria
06/14/2000CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line
06/14/2000CN1256277A Phytostrin and/or phytosteroidal alkanol derivative
06/14/2000CN1256276A Intermediate of beta 3-adrenalin energy receptor protagonist and its synthesis method
06/14/2000CN1256141A Itching-stopping chili liquid and its preparation
06/14/2000CN1256126A Composite medicine for optical dynamic treatment of tumor
06/14/2000CN1256125A New application of schisandra essence
06/14/2000CN1053450C Complete synthesizing process for compound of 17-substituted 11 beta-substituted aromatic base 4,9-estradiene
06/14/2000CN1053448C Compound useful as antiproliferative agents and GARFT inhibitors
06/14/2000CN1053446C Novel thiomarinol derivatives and their prepn.
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/14/2000CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them
06/14/2000CN1053437C Synthetic method for lisinopril
1 ... 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 6320 6321 ... 7860